Rx-360 publishes pharma supply chain security guide

Pharmaceutical industry group Rx-360 has published a new report to help drugmakers tackle the illicit trade in medicines and protect their supply chains.

The new document – Responding to the Threat of Illicit Medicines: Methodologies for Monitoring, Investigation & Stakeholder Engagement – provides a high-level summary of supply chain security (SCS) monitoring practices and tools that pharmaceutical companies can use “to help detect, deter, and to establish appropriate control for illicit medicines in the supply chain,” according to the group.

“Considering that patient safety is the priority for industry, pharmaceutical manufacturers should have a process dedicated to the identification and prevention of illicit medicines in the marketplace,” says Rx-360.

The report can be downloaded here.